Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

被引:2
作者
Buse, Dawn C. [1 ]
Nahas, Stephanie J. [2 ]
Stewart, Walter F. [3 ]
Armand, Cynthia E. [1 ]
Reed, Michael L. [4 ]
Fanning, Kristina M. [5 ]
Adams, Aubrey Manack [6 ]
Lipton, Richard B. [1 ]
机构
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Medcurio, Oakland, CA USA
[4] Vedanta Res, Chapel Hill, NC USA
[5] MIST Res, Wilmington, NC USA
[6] AbbVie, 2525 Dupont Dr, Irvine, CA 92612 USA
关键词
absenteeism; presenteeism; headache; migraine; employment; disability; productivity; QUALITY-OF-LIFE; AMERICAN-MIGRAINE; EPISODIC MIGRAINE; WORK IMPACT; HEADACHE; DISABILITY; PREVALENCE; BURDEN; IMPAIRMENT; ALLODYNIA;
D O I
10.1097/JOM.0000000000002801
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: This study aimed to ascertain whether level of optimization of acute treatment of migraine is related to work productivity across the spectrum of migraine.Methods: Data were from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study, an internet-based longitudinal survey. Respondents with migraine who reported full-time employment and use of >= 1 acute prescription medication for migraine were included. We determined relationships among lost productive time (LPT; measured with the Migraine Disability Assessment Scale), acute treatment optimization (Migraine Treatment Optimization Questionnaire- ), and monthly headache days (MHDs). Results: There was a direct relationship between LPT and MHD category. Greater acute treatment optimization was associated with lower total LPT, less absenteeism, and less presenteeism within each MHD category. Conclusions: Optimizing acute treatment for migraine may reduce LPT in people with migraine and reduce indirect costs.
引用
收藏
页码:E261 / E268
页数:8
相关论文
共 50 条
  • [31] Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) study
    Shapiro, Robert E.
    Viktrup, Lars
    Muenzel, Eva Jolanda
    Buse, Dawn C.
    Zagar, Anthony J.
    Ashina, Sait
    Hutchinson, Susan
    Nicholson, Robert A.
    Lipton, Richard B.
    BMC NEUROLOGY, 2025, 25 (01)
  • [32] Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Ezzati, Ali
    Buse, Dawn C.
    Fanning, Kristina M.
    Reed, Michael L.
    Martin, Vincent T.
    Lipton, Richard B.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 223
  • [33] Factors Associated With Triptan Use in Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study
    Chu, Min Kyung
    Buse, Dawn C.
    Bigal, Marcelo E.
    Serrano, Daniel
    Lipton, Richard B.
    HEADACHE, 2012, 52 (02): : 213 - 223
  • [34] Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
    Lipton, Richard B.
    Fanning, Kristina M.
    Serrano, Daniel
    Reed, Michael L.
    Cady, Roger
    Buse, Dawn C.
    NEUROLOGY, 2015, 84 (07) : 688 - 695
  • [35] Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
    Hirata, Koichi
    Ueda, Kaname
    Ye, Wenyu
    Kim, Yongin
    Komori, Mika
    Jackson, James
    Cotton, Sarah
    Rajan, Narayan
    Treuer, Tamas
    BMC NEUROLOGY, 2020, 20 (01)
  • [36] Burden of migraine related to menses: results from the AMPP study
    Pavlovic, Jelena M.
    Stewart, Walter F.
    Bruce, Christa A.
    Gorman, Jennifer A.
    Sun, Haiyan
    Buse, Dawn C.
    Lipton, Richard B.
    JOURNAL OF HEADACHE AND PAIN, 2015, 16
  • [37] Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey
    Martelletti, Paolo
    Schwedt, Todd J.
    Vo, Pamela
    Ritrovato, Daniela
    Reilly, Margaret C.
    Naclerio, Mariantonietta
    Ranjan, Pallavi
    Kleebach, Joern
    Joshi, Parth
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 717 - 726
  • [38] Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
    Todd J. Schwedt
    Aftab Alam
    Michael L. Reed
    Kristina M. Fanning
    Sagar Munjal
    Dawn C. Buse
    David W. Dodick
    Richard B. Lipton
    The Journal of Headache and Pain, 2018, 19
  • [39] Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study
    Lipton, Richard B.
    Buse, Dawn C.
    Dodick, David W.
    Schwedt, Todd J.
    Singh, Preeti
    Munjal, Sagar
    Fanning, Kristina
    Bostic, Ryan
    Reed, Michael L.
    HEADACHE, 2021, 61 (01): : 103 - 116
  • [40] Impact of Migraine Treatment on Economic Burden and Workplace Productivity Among Migraineurs Employed in Schools: A Prospective Study
    Sen, Cigdem
    Karli, Necdet
    Zarifoglu, Mehmet
    Pala, Kayihan
    Seferoglu, Meral
    Ozkaya, Guven
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2011, 28 (04): : 465 - 474